Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jul;8(3):357–375. doi: 10.1128/cmr.8.3.357

Chancroid and Haemophilus ducreyi: an update.

D L Trees 1, S A Morse 1
PMCID: PMC174629  PMID: 7553570

Abstract

Haemophilus ducreyi is a fastidious gram-negative bacillus that causes the sexually transmitted infection chancroid. Chancroid is a major genital ulcerative disease in Africa, Southeast Asia, the Caribbean, and Latin America and is of increasing concern in the United States. Genital ulcerative disease and chancroid in particular have been associated with facilitating the transmission of human immunodeficiency virus. The diagnosis of chancroid based on the clinical appearance of the genital lesion or on the isolation of H. ducreyi on selective medium is relatively insensitive. However, recent advances in nonculture diagnostic tests have enhanced our ability to diagnose chancroid. There has been renewed interest in understanding the pathogenesis of H. ducreyi. In vitro and in vivo models have been developed to help identify important virulence determinants. Through the use of biochemical and molecular techniques, macromolecular components that may be important in virulence have been identified.

Full Text

The Full Text of this article is available as a PDF (512.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeck D., Eckert F., Korting H. C. Atypical presentation of co-existent Haemophilus ducreyi and Treponema pallidum infection in an HIV-positive male. Acta Derm Venereol. 1992;72(1):37–38. [PubMed] [Google Scholar]
  2. Abeck D., Johnson A. P., Hartinger A., Kollmann M., Korting H. C., Ballard R. C., Braun-Falco O. Absence of extracellular enzyme activity and cytotoxicity in cell-free culture filtrates of Haemophilus ducreyi. Microb Pathog. 1991 May;10(5):405–410. doi: 10.1016/0882-4010(91)90085-o. [DOI] [PubMed] [Google Scholar]
  3. Abeck D., Johnson A. P., Korting H. C., Stolz W., Struck-Sauer E., Braun-Falco O. Effect of iron limitation on protein composition and ultrastructure of Haemophilus ducreyi. FEMS Microbiol Lett. 1990 Mar 1;56(1-2):41–44. doi: 10.1111/j.1574-6968.1990.tb04119.x. [DOI] [PubMed] [Google Scholar]
  4. Abeck D., Korting H. C., Kollmann M., Johnson A. P., Ballard R. C., Mensing H. Lack of immunoglobulin A1 protease production by Haemophilus ducreyi. Zentralbl Bakteriol. 1992 Jun;277(1):34–38. doi: 10.1016/s0934-8840(11)80868-6. [DOI] [PubMed] [Google Scholar]
  5. Albritton W. L. Biology of Haemophilus ducreyi. Microbiol Rev. 1989 Dec;53(4):377–389. doi: 10.1128/mr.53.4.377-389.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Albritton W. L., Brunton J. L., Slaney L., MacLean I. Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Jan;21(1):159–165. doi: 10.1128/aac.21.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Albritton W. L., Maclean I. W., Slaney L. A., Ronald A. R., Deneer H. G. Plasmid-mediated tetracycline resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1984 Feb;25(2):187–190. doi: 10.1128/aac.25.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Aldridge K. E., Cammarata C., Martin D. H. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi. Antimicrob Agents Chemother. 1993 Sep;37(9):1986–1988. doi: 10.1128/aac.37.9.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Alfa M. J. Cytopathic effect of Haemophilus ducreyi for human foreskin cell culture. J Med Microbiol. 1992 Jul;37(1):43–50. doi: 10.1099/00222615-37-1-43. [DOI] [PubMed] [Google Scholar]
  10. Alfa M. J., DeGagne P. A quantitative chemiluminescent ribosomal probe method for monitoring adherence of Haemophilus ducreyi to eukaryotic cells. Microb Pathog. 1994 Sep;17(3):167–174. doi: 10.1006/mpat.1994.1063. [DOI] [PubMed] [Google Scholar]
  11. Alfa M. J., Degagne P., Hollyer T. Haemophilus ducreyi adheres to but does not invade cultured human foreskin cells. Infect Immun. 1993 May;61(5):1735–1742. doi: 10.1128/iai.61.5.1735-1742.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Alfa M. J., Olson N., Degagne P., Plummer F., Namaara W., Maclean I., Ronald A. R. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi. J Infect Dis. 1993 May;167(5):1206–1210. doi: 10.1093/infdis/167.5.1206. [DOI] [PubMed] [Google Scholar]
  13. Alfa M. J., Olson N., Degagne P., Slaney L., Plummer F., Namaara W., Ronald A. R. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans. Sex Transm Dis. 1992 Nov-Dec;19(6):309–314. [PubMed] [Google Scholar]
  14. Alfa M. J., Yang C. L., Slaney L. A., Kwok A. Y., Ronald A. R., Jay F. T. Identification of highly conserved and species-specific polypeptides of Haemophilus ducreyi. J Med Microbiol. 1992 Dec;37(6):413–419. doi: 10.1099/00222615-37-6-413. [DOI] [PubMed] [Google Scholar]
  15. Anderson J. E., Dahlberg L. L. High-risk sexual behavior in the general population. Results from a national survey, 1988-1990. Sex Transm Dis. 1992 Nov-Dec;19(6):320–325. [PubMed] [Google Scholar]
  16. Arko R. J. Neisseria gonorrhoeae: experimental infection of laboratory animals. Science. 1972 Sep 29;177(4055):1200–1201. doi: 10.1126/science.177.4055.1200. [DOI] [PubMed] [Google Scholar]
  17. Bilgeri Y. R., Ballard R. C., Duncan M. O., Mauff A. C., Koornhof H. J. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg. Antimicrob Agents Chemother. 1982 Oct;22(4):686–688. doi: 10.1128/aac.22.4.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Blackmore C. A., Limpakarnjanarat K., Rigau-Pérez J. G., Albritton W. L., Greenwood J. R. An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. J Infect Dis. 1985 May;151(5):840–844. doi: 10.1093/infdis/151.5.840. [DOI] [PubMed] [Google Scholar]
  19. Brentjens R. J., Spinola S. M., Campagnari A. A. Haemophilus ducreyi adheres to human keratinocytes. Microb Pathog. 1994 Mar;16(3):243–247. doi: 10.1006/mpat.1994.1025. [DOI] [PubMed] [Google Scholar]
  20. Brown T. J., Ison C. A. Non-radioactive ribotyping of Haemophilus ducreyi using a digoxigenin labelled cDNA probe. Epidemiol Infect. 1993 Apr;110(2):289–295. doi: 10.1017/s0950268800068229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Brown T. J., Jardine J., Ison C. A. Antibodies directed against Haemophilus ducreyi heat shock proteins. Microb Pathog. 1993 Aug;15(2):131–139. doi: 10.1006/mpat.1993.1063. [DOI] [PubMed] [Google Scholar]
  22. Brunton J., Meier M., Ehrman N., Maclean I., Slaney L., Albritton W. L. Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Jun;21(6):857–863. doi: 10.1128/aac.21.6.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cameron D. W., Simonsen J. N., D'Costa L. J., Ronald A. R., Maitha G. M., Gakinya M. N., Cheang M., Ndinya-Achola J. O., Piot P., Brunham R. C. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989 Aug 19;2(8660):403–407. doi: 10.1016/s0140-6736(89)90589-8. [DOI] [PubMed] [Google Scholar]
  24. Campagnari A. A., Karalus R., Apicella M., Melaugh W., Lesse A. J., Gibson B. W. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis. Infect Immun. 1994 Jun;62(6):2379–2386. doi: 10.1128/iai.62.6.2379-2386.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Campagnari A. A., Spinola S. M., Lesse A. J., Kwaik Y. A., Mandrell R. E., Apicella M. A. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens. Microb Pathog. 1990 May;8(5):353–362. doi: 10.1016/0882-4010(90)90094-7. [DOI] [PubMed] [Google Scholar]
  26. Campagnari A. A., Wild L. M., Griffiths G. E., Karalus R. J., Wirth M. A., Spinola S. M. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Infect Immun. 1991 Aug;59(8):2601–2608. doi: 10.1128/iai.59.8.2601-2608.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chapel T. A., Brown W. J., Jeffres C., Stewart J. A. How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis. 1977 Oct-Dec;4(4):150–152. doi: 10.1097/00007435-197710000-00008. [DOI] [PubMed] [Google Scholar]
  28. Chui L., Albritton W., Paster B., Maclean I., Marusyk R. Development of the polymerase chain reaction for diagnosis of chancroid. J Clin Microbiol. 1993 Mar;31(3):659–664. doi: 10.1128/jcm.31.3.659-664.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Cunningham A. L., Turner R. R., Miller A. C., Para M. F., Merigan T. C. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest. 1985 Jan;75(1):226–233. doi: 10.1172/JCI111678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. DEACON W. E., OLANSKY S., ALBRITTON D. C., KAPLAN W. VDRL chancroid studies. IV. Experimental chancroid, prophylaxis and treatment. Antibiotic Med Clin Ther (New York) 1956 Mar;2(3):143–147. [PubMed] [Google Scholar]
  31. Dangor Y., Ballard R. C., Miller S. D., Koornhof H. J. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1990 Jul;34(7):1303–1307. doi: 10.1128/aac.34.7.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dangor Y., Ballard R. C., da L Exposto F., Fehler G., Miller S. D., Koornhof H. J. Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis. 1990 Oct-Dec;17(4):184–189. doi: 10.1097/00007435-199010000-00007. [DOI] [PubMed] [Google Scholar]
  33. Dangor Y., Miller S. D., Koornhof H. J., Ballard R. C. A simple medium for the primary isolation of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):930–934. doi: 10.1007/BF01962377. [DOI] [PubMed] [Google Scholar]
  34. Dangor Y., Radebe F., Ballard R. C. Transport media for Haemophilus ducreyi. Sex Transm Dis. 1993 Jan-Feb;20(1):5–9. doi: 10.1097/00007435-199301000-00002. [DOI] [PubMed] [Google Scholar]
  35. Daniels K. C., Ferneyhough H. S. Specific direct fluorescent antibody detection of Treponema pallidum. Health Lab Sci. 1977 Jul;14(3):164–171. [PubMed] [Google Scholar]
  36. De Ley J., Mannheim W., Mutters R., Piechulla K., Tytgat R., Segers P., Bisgaard M., Frederiksen W., Hinz K. H., Vanhoucke M. Inter- and intrafamilial similarities of rRNA cistrons of the Pasteurellaceae. Int J Syst Bacteriol. 1990 Apr;40(2):126–137. doi: 10.1099/00207713-40-2-126. [DOI] [PubMed] [Google Scholar]
  37. Deneer H. G., Slaney L., Maclean I. W., Albritton W. L. Mobilization of nonconjugative antibiotic resistance plasmids in Haemophilus ducreyi. J Bacteriol. 1982 Feb;149(2):726–732. doi: 10.1128/jb.149.2.726-732.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Denys G. A., Chapel T. A., Jeffries C. D. An indirect fluorescent antibody technique for Haemophilus ducreyi. Health Lab Sci. 1978 Jul;15(3):128–132. [PubMed] [Google Scholar]
  39. Desjardins M., Thompson C. E., Filion L. G., Ndinya-Achola J. O., Plummer F. A., Ronald A. R., Piot P., Cameron D. W. Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi. J Clin Microbiol. 1992 Aug;30(8):2019–2024. doi: 10.1128/jcm.30.8.2019-2024.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Dewhirst F. E., Paster B. J., Olsen I., Fraser G. J. Phylogeny of 54 representative strains of species in the family Pasteurellaceae as determined by comparison of 16S rRNA sequences. J Bacteriol. 1992 Mar;174(6):2002–2013. doi: 10.1128/jb.174.6.2002-2013.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dixon L. G., Albritton W. L., Willson P. J. An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. Plasmid. 1994 Sep;32(2):228–232. doi: 10.1006/plas.1994.1060. [DOI] [PubMed] [Google Scholar]
  42. Engelkens H. J., ten Kate F. J., Judanarso J., Vuzevski V. D., van Lier J. B., Godschalk J. C., van der Sluis J. J., Stolz E. The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med. 1993 Apr;69(2):102–107. doi: 10.1136/sti.69.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Farris J. R., Hutcheson D., Cartwright G., Glover J. H. Chancroid in Dallas: new lessons from an old disease. Tex Med. 1991 May;87(5):78–81. [PubMed] [Google Scholar]
  44. Fast M. V., D'Costa L. J., Nsanze H., Piot P., Curran J., Karasira P., Mirza N., Maclean I. W., Ronald A. R. The clinical diagnosis of genital ulcer disease in men in the tropics. Sex Transm Dis. 1984 Apr-Jun;11(2):72–76. doi: 10.1097/00007435-198404000-00004. [DOI] [PubMed] [Google Scholar]
  45. Figueroa J. P., Brathwaite A., Morris J., Ward E., Peruga A., Blattner W., Vermund S. H., Hayes R. Rising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: traumatic sex and genital ulcers as risk factors. J Acquir Immune Defic Syndr. 1994 Mar;7(3):310–316. [PubMed] [Google Scholar]
  46. Finelli L., Budd J., Spitalny K. C. Early syphilis. Relationship to sex, drugs, and changes in high-risk behavior from 1987-1990. Sex Transm Dis. 1993 Mar-Apr;20(2):89–95. [PubMed] [Google Scholar]
  47. Finn G. Y., Karim Q. N., Easmon C. S. The production and characterisation of rabbit antiserum and murine monoclonal antibodies to Haemophilus ducreyi. J Med Microbiol. 1990 Mar;31(3):219–224. doi: 10.1099/00222615-31-3-219. [DOI] [PubMed] [Google Scholar]
  48. Fita I., Rossmann M. G. The active center of catalase. J Mol Biol. 1985 Sep 5;185(1):21–37. doi: 10.1016/0022-2836(85)90180-9. [DOI] [PubMed] [Google Scholar]
  49. Flood J. M., Sarafian S. K., Bolan G. A., Lammel C., Engelman J., Greenblatt R. M., Brooks G. F., Back A., Morse S. A. Multistrain outbreak of chancroid in San Francisco, 1989-1991. J Infect Dis. 1993 May;167(5):1106–1111. doi: 10.1093/infdis/167.5.1106. [DOI] [PubMed] [Google Scholar]
  50. Guzmán M., Guzmán J., Bernal M. Treatment of chancroid with a single dose of spectinomycin. Sex Transm Dis. 1992 Sep-Oct;19(5):291–294. doi: 10.1097/00007435-199209000-00010. [DOI] [PubMed] [Google Scholar]
  51. Hammond G. W., Lian C. J., Wilt J. C., Albritton W. L., Ronald A. R. Determination of the hemin requirement of Haemophilus ducreyi: evaluation of the porphyrin test and media used in the satellite growth test. J Clin Microbiol. 1978 Mar;7(3):243–246. doi: 10.1128/jcm.7.3.243-246.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1978 Apr;13(4):608–612. doi: 10.1128/aac.13.4.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol. 1978 Jan;7(1):39–43. doi: 10.1128/jcm.7.1.39-43.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hansen E. J., Latimer J. L., Thomas S. E., Helminen M., Albritton W. L., Radolf J. D. Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. J Bacteriol. 1992 Aug;174(16):5442–5449. doi: 10.1128/jb.174.16.5442-5449.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hansen E. J., Loftus T. A. Monoclonal antibodies reactive with all strains of Haemophilus ducreyi. Infect Immun. 1984 Apr;44(1):196–198. doi: 10.1128/iai.44.1.196-198.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hollyer T. T., DeGagne P. A., Alfa M. J. Characterization of the cytopathic effect of Haemophilus ducreyi. Sex Transm Dis. 1994 Sep-Oct;21(5):247–257. doi: 10.1097/00007435-199409000-00002. [DOI] [PubMed] [Google Scholar]
  57. Jardine J. L., Miller S. D., Koornhof H. J. Inhibitory effect of fetal calf serum on the growth of Haemophilus ducreyi. J Infect. 1990 Sep;21(2):223–225. doi: 10.1016/0163-4453(90)91987-o. [DOI] [PubMed] [Google Scholar]
  58. Johnson S. R., Martin D. H., Cammarata C., Morse S. A. Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid. J Clin Microbiol. 1995 Apr;33(4):1036–1038. doi: 10.1128/jcm.33.4.1036-1038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Johnson S. R., Martin D. H., Cammarata C., Morse S. A. Development of a polymerase chain reaction assay for the detection of Haemophilus ducreyi. Sex Transm Dis. 1994 Jan-Feb;21(1):13–23. doi: 10.1097/00007435-199401000-00004. [DOI] [PubMed] [Google Scholar]
  60. Jones C., Rosen T., Clarridge J., Collins S. Chancroid: results from an outbreak in Houston, Texas. South Med J. 1990 Dec;83(12):1384–1389. [PubMed] [Google Scholar]
  61. Karim Q. N., Finn G. Y., Easmon C. S., Dangor Y., Dance D. A., Ngeow Y. F., Ballard R. C. Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody: a preliminary evaluation. Genitourin Med. 1989 Dec;65(6):361–365. doi: 10.1136/sti.65.6.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Knapp J. S., Back A. F., Babst A. F., Taylor D., Rice R. J. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob Agents Chemother. 1993 Jul;37(7):1552–1555. doi: 10.1128/aac.37.7.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Korting H. C., Abeck D., Johnson A. P., Ballard R. C., Taylor-Robinson D., Braun-Falco O. Lectin typing of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):678–680. doi: 10.1007/BF01964253. [DOI] [PubMed] [Google Scholar]
  64. Kreiss J. K., Coombs R., Plummer F., Holmes K. K., Nikora B., Cameron W., Ngugi E., Ndinya Achola J. O., Corey L. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis. 1989 Sep;160(3):380–384. doi: 10.1093/infdis/160.3.380. [DOI] [PubMed] [Google Scholar]
  65. Kreiss J. K., Koech D., Plummer F. A., Holmes K. K., Lightfoote M., Piot P., Ronald A. R., Ndinya-Achola J. O., D'Costa L. J., Roberts P. AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med. 1986 Feb 13;314(7):414–418. doi: 10.1056/NEJM198602133140704. [DOI] [PubMed] [Google Scholar]
  66. Lagergård T., Purvén M., Frisk A. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. Microb Pathog. 1993 Jun;14(6):417–431. doi: 10.1006/mpat.1993.1041. [DOI] [PubMed] [Google Scholar]
  67. Lagergård T., Purvén M. Neutralizing antibodies to Haemophilus ducreyi cytotoxin. Infect Immun. 1993 Apr;61(4):1589–1592. doi: 10.1128/iai.61.4.1589-1592.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Lagergård T. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Microb Pathog. 1992 Sep;13(3):203–217. doi: 10.1016/0882-4010(92)90021-f. [DOI] [PubMed] [Google Scholar]
  69. Lammel C. J., Dekker N. P., Palefsky J., Brooks G. F. In vitro model of Haemophilus ducreyi adherence to and entry into eukaryotic cells of genital origin. J Infect Dis. 1993 Mar;167(3):642–650. doi: 10.1093/infdis/167.3.642. [DOI] [PubMed] [Google Scholar]
  70. Lee B. C. Iron sources for Haemophilus ducreyi. J Med Microbiol. 1991 Jun;34(6):317–322. doi: 10.1099/00222615-34-6-317. [DOI] [PubMed] [Google Scholar]
  71. Lockett A. E., Dance D. A., Mabey D. C., Drasar B. S. Serum-free media for isolation of Haemophilus ducreyi. Lancet. 1991 Aug 3;338(8762):326–326. doi: 10.1016/0140-6736(91)90473-3. [DOI] [PubMed] [Google Scholar]
  72. MacDonald K. S., Cameron D. W., D'Costa L., Ndinya-Achola J. O., Plummer F. A., Ronald A. R. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother. 1989 May;33(5):612–614. doi: 10.1128/aac.33.5.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. MacLean I. W., Bowden G. H., Albritton W. L. TEM-type beta-lactamase production in Haemophilus ducreyi. Antimicrob Agents Chemother. 1980 May;17(5):897–900. doi: 10.1128/aac.17.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Macdonald K., Cameron D. W., Irungu G., D'Costa L. J., Plummer F. A., Slaney L. A., Ndinya-Achola J. O., Ronald A. R. Comparison of Sheffield media with standard media for the isolation of Haemophilus ducreyi. Sex Transm Dis. 1989 Apr-Jun;16(2):88–90. doi: 10.1097/00007435-198904000-00009. [DOI] [PubMed] [Google Scholar]
  75. Mandrell R. E., Griffiss J. M., Macher B. A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med. 1988 Jul 1;168(1):107–126. doi: 10.1084/jem.168.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Marshall B., Roberts M., Smith A., Levy S. B. Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. J Infect Dis. 1984 Jun;149(6):1028–1029. doi: 10.1093/infdis/149.6.1028. [DOI] [PubMed] [Google Scholar]
  77. Martin D. H., DiCarlo R. P. Recent changes in the epidemiology of genital ulcer disease in the United States. The crack cocaine connection. Sex Transm Dis. 1994 Mar-Apr;21(2 Suppl):S76–S80. [PubMed] [Google Scholar]
  78. Marx R., Aral S. O., Rolfs R. T., Sterk C. E., Kahn J. G. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun;18(2):92–101. doi: 10.1097/00007435-199118020-00008. [DOI] [PubMed] [Google Scholar]
  79. Melaugh W., Phillips N. J., Campagnari A. A., Karalus R., Gibson B. W. Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease. J Biol Chem. 1992 Jul 5;267(19):13434–13439. [PubMed] [Google Scholar]
  80. Melaugh W., Phillips N. J., Campagnari A. A., Tullius M. V., Gibson B. W. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. Biochemistry. 1994 Nov 8;33(44):13070–13078. doi: 10.1021/bi00248a016. [DOI] [PubMed] [Google Scholar]
  81. Mietzner T. A., Morse S. A. The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr. 1994;14:471–493. doi: 10.1146/annurev.nu.14.070194.002351. [DOI] [PubMed] [Google Scholar]
  82. Morse S. A. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev. 1989 Apr;2(2):137–157. doi: 10.1128/cmr.2.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Morse S. A., McDade J. E. Recommendations for working with pathogenic bacteria. HHS, NIH, CDC. Methods Enzymol. 1994;235:1–26. doi: 10.1016/0076-6879(94)35127-9. [DOI] [PubMed] [Google Scholar]
  84. Motley M., Sarafian S. K., Knapp J. S., Zaidi A. A., Schmid G. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States. Antimicrob Agents Chemother. 1992 Aug;36(8):1639–1643. doi: 10.1128/aac.36.8.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Museyi K., Van Dyck E., Vervoort T., Taylor D., Hoge C., Piot P. Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi. J Infect Dis. 1988 May;157(5):1039–1043. doi: 10.1093/infdis/157.5.1039. [DOI] [PubMed] [Google Scholar]
  86. O'Farrell N., Hoosen A. A., Coetzee K. D., van den Ende J. Genital ulcer disease: accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourin Med. 1994 Feb;70(1):7–11. doi: 10.1136/sti.70.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Oberhofer T. R., Back A. E. Isolation and cultivation of Haemophilus ducreyi. J Clin Microbiol. 1982 Apr;15(4):625–629. doi: 10.1128/jcm.15.4.625-629.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Odumeru J. A., Alfa M. J., Martin C. F., Ronald A. R., Jay F. T. Production of monoclonal antibodies specific for Haemophilus ducreyi: a screening method to discriminate specific and cross-reacting antibodies. Hybridoma. 1989 Jun;8(3):337–351. doi: 10.1089/hyb.1989.8.337. [DOI] [PubMed] [Google Scholar]
  89. Odumeru J. A., Wiseman G. M., Ronald A. R. Virulence factors of Haemophilus ducreyi. Infect Immun. 1984 Feb;43(2):607–611. doi: 10.1128/iai.43.2.607-611.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Ortíz-Zepeda C., Hernández-Pérez E., Marroquín-Burgos R. Gross and microscopic features in chancroid: a study in 200 new culture-proven cases in San Salvador. Sex Transm Dis. 1994 Mar-Apr;21(2):112–117. doi: 10.1097/00007435-199403000-00011. [DOI] [PubMed] [Google Scholar]
  91. Palmer K. L., Grass S., Munson R. S., Jr Identification of a hemolytic activity elaborated by Haemophilus ducreyi. Infect Immun. 1994 Jul;62(7):3041–3043. doi: 10.1128/iai.62.7.3041-3043.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Parsons L. M., Shayegani M., Waring A. L., Bopp L. H. DNA probes for the identification of Haemophilus ducreyi. J Clin Microbiol. 1989 Jul;27(7):1441–1445. doi: 10.1128/jcm.27.7.1441-1445.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Parsons L. M., Waring A. L., Shayegani M. Molecular analysis of the Haemophilus ducreyi groE heat shock operon. Infect Immun. 1992 Oct;60(10):4111–4118. doi: 10.1128/iai.60.10.4111-4118.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Pepin J., Dunn D., Gaye I., Alonso P., Egboga A., Tedder R., Piot P., Berry N., Schellenberg D., Whittle H. HIV-2 infection among prostitutes working in The Gambia: association with serological evidence of genital ulcer diseases and with generalized lymphadenopathy. AIDS. 1991 Jan;5(1):69–75. [PubMed] [Google Scholar]
  95. Plourde P. J., D'Costa L. J., Agoki E., Ombette J., Ndinya-Achola J. O., Slaney L. A., Ronald A. R., Plummer F. A. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis. 1992 May;165(5):949–952. doi: 10.1093/infdis/165.5.949. [DOI] [PubMed] [Google Scholar]
  96. Plummer F. A., D'Costa L. J., Nsanze H., Karasira P., MacLean I. W., Piot P., Ronald A. R. Clinical and microbiologic studies of genital ulcers in Kenyan women. Sex Transm Dis. 1985 Oct-Dec;12(4):193–197. doi: 10.1097/00007435-198510000-00005. [DOI] [PubMed] [Google Scholar]
  97. Plummer F. A., Simonsen J. N., Cameron D. W., Ndinya-Achola J. O., Kreiss J. K., Gakinya M. N., Waiyaki P., Cheang M., Piot P., Ronald A. R. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1991 Feb;163(2):233–239. doi: 10.1093/infdis/163.2.233. [DOI] [PubMed] [Google Scholar]
  98. Plummer F. A., Wainberg M. A., Plourde P., Jessamine P., D'Costa L. J., Wamola I. A., Ronald A. R. Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification. J Infect Dis. 1990 Apr;161(4):810–811. doi: 10.1093/infdis/161.4.810. [DOI] [PubMed] [Google Scholar]
  99. Purcell B. K., Richardson J. A., Radolf J. D., Hansen E. J. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. J Infect Dis. 1991 Aug;164(2):359–367. doi: 10.1093/infdis/164.2.359. [DOI] [PubMed] [Google Scholar]
  100. Purvén M., Lagergård T. Haemophilus ducreyi, a cytotoxin-producing bacterium. Infect Immun. 1992 Mar;60(3):1156–1162. doi: 10.1128/iai.60.3.1156-1162.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Quale J., Teplitz E., Augenbraun M. Atypical presentation of chancroid in a patient infected with the human immunodeficiency virus. Am J Med. 1990 May;88(5N):43N–44N. [PubMed] [Google Scholar]
  102. Rice P. A., Vayo H. E., Tam M. R., Blake M. S. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med. 1986 Nov 1;164(5):1735–1748. doi: 10.1084/jem.164.5.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Roberts M. C., Actis L. A., Crosa J. H. Molecular characterization of chloramphenicol-resistant Haemophilus parainfluenzae and Haemophilus ducreyi. Antimicrob Agents Chemother. 1985 Aug;28(2):176–180. doi: 10.1128/aac.28.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Roberts M. C. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother. 1990 Mar;34(3):476–478. doi: 10.1128/aac.34.3.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Roberts M. C., Knapp J. S. Transfer of beta-lactamase plasmids from Neisseria gonorrhoeae to Neisseria meningitidis and commensal Neisseria species by the 25.2-megadalton conjugative plasmid. Antimicrob Agents Chemother. 1988 Sep;32(9):1430–1432. doi: 10.1128/aac.32.9.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Roberts M. C. Plasmid-mediated Tet M in Haemophilus ducreyi. Antimicrob Agents Chemother. 1989 Sep;33(9):1611–1613. doi: 10.1128/aac.33.9.1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Roggen E. L., De Breucker S., van Dyck E., Piot P. Antigenic diversity in Haemophilus ducreyi as shown by western blot (immunoblot) analysis. Infect Immun. 1992 Feb;60(2):590–595. doi: 10.1128/iai.60.2.590-595.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Roggen E. L., Hoofd G., Van Dyck E., Piot P. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies. Sex Transm Dis. 1994 Jan-Feb;21(1):36–42. doi: 10.1097/00007435-199401000-00008. [DOI] [PubMed] [Google Scholar]
  109. Rolfs R. T., Goldberg M., Sharrar R. G. Risk factors for syphilis: cocaine use and prostitution. Am J Public Health. 1990 Jul;80(7):853–857. doi: 10.2105/ajph.80.7.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Rossau R., Duhamel M., Jannes G., Decourt J. L., Van Heuverswyn H. The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid. J Gen Microbiol. 1991 Feb;137(2):277–285. doi: 10.1099/00221287-137-2-277. [DOI] [PubMed] [Google Scholar]
  111. Sanson-le Pors M. J., Casin I. M., Collatz E. Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi. Antimicrob Agents Chemother. 1985 Aug;28(2):315–319. doi: 10.1128/aac.28.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Sarafian S. K., Johnson S. R., Thomas M. L., Knapp J. S. Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand. J Clin Microbiol. 1991 Oct;29(10):2333–2334. doi: 10.1128/jcm.29.10.2333-2334.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Sarafian S. K., Knapp J. S. Molecular epidemiology, based on plasmid profiles, of Haemophilus ducreyi infections in the United States. Results of surveillance, 1981-1990. Sex Transm Dis. 1992 Jan-Feb;19(1):35–38. doi: 10.1097/00007435-199201000-00007. [DOI] [PubMed] [Google Scholar]
  114. Sarafian S. K., Woods T. C., Knapp J. S., Swaminathan B., Morse S. A. Molecular characterization of Haemophilus ducreyi by ribosomal DNA fingerprinting. J Clin Microbiol. 1991 Sep;29(9):1949–1954. doi: 10.1128/jcm.29.9.1949-1954.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Schalla W. O., Sanders L. L., Schmid G. P., Tam M. R., Morse S. A. Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid. J Infect Dis. 1986 May;153(5):879–887. doi: 10.1093/infdis/153.5.879. [DOI] [PubMed] [Google Scholar]
  116. Schweda E. K., Sundström A. C., Eriksson L. M., Jonasson J. A., Lindberg A. A. Structural studies of the cell envelope lipopolysaccharides from Haemophilus ducreyi strains ITM 2665 and ITM 4747. J Biol Chem. 1994 Apr 22;269(16):12040–12048. [PubMed] [Google Scholar]
  117. Seidman S. N., Sterk-Elifson C., Aral S. O. High-risk sexual behavior among drug-using men. Sex Transm Dis. 1994 May-Jun;21(3):173–180. doi: 10.1097/00007435-199405000-00008. [DOI] [PubMed] [Google Scholar]
  118. Shah L., Davies H. A., Wall R. A. Association of Haemophilus ducreyi with cell-culture lines. J Med Microbiol. 1992 Oct;37(4):268–272. doi: 10.1099/00222615-37-4-268. [DOI] [PubMed] [Google Scholar]
  119. Slootmans L., Vanden Berghe D. A., Van Dyck E., Piot P. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products. Antimicrob Agents Chemother. 1983 Oct;24(4):564–567. doi: 10.1128/aac.24.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Sng E. H., Lim A. L., Rajan V. S., Goh A. J. Characteristics of Haemophilus ducreyi. A study. Br J Vener Dis. 1982 Aug;58(4):239–242. doi: 10.1136/sti.58.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Spinola S. M., Castellazzo A., Shero M., Apicella M. A. Characterization of pili expressed by Haemophilus ducreyi. Microb Pathog. 1990 Dec;9(6):417–426. doi: 10.1016/0882-4010(90)90060-4. [DOI] [PubMed] [Google Scholar]
  122. Spinola S. M., Griffiths G. E., Bogdan J., Menegus M. A. Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect Immun. 1992 Feb;60(2):385–391. doi: 10.1128/iai.60.2.385-391.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Spinola S. M., Griffiths G. E., Shanks K. L., Blake M. S. The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteins. Infect Immun. 1993 Apr;61(4):1346–1351. doi: 10.1128/iai.61.4.1346-1351.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Spinola S. M., Wild L. M., Apicella M. A., Gaspari A. A., Campagnari A. A. Experimental human infection with Haemophilus ducreyi. J Infect Dis. 1994 May;169(5):1146–1150. doi: 10.1093/infdis/169.5.1146. [DOI] [PubMed] [Google Scholar]
  125. Sturm A. W., Stolting G. J., Cormane R. H., Zanen H. C. Clinical and microbiological evaluation of 46 episodes of genital ulceration. Genitourin Med. 1987 Apr;63(2):98–101. doi: 10.1136/sti.63.2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Totten P. A., Handsfield H. H., Peters D., Holmes K. K., Falkow S. Characterization of ampicillin resistance plasmids from Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Apr;21(4):622–627. doi: 10.1128/aac.21.4.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Totten P. A., Lara J. C., Norn D. V., Stamm W. E. Haemophilus ducreyi attaches to and invades human epithelial cells in vitro. Infect Immun. 1994 Dec;62(12):5632–5640. doi: 10.1128/iai.62.12.5632-5640.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Totten P. A., Morton W. R., Knitter G. H., Clark A. M., Kiviat N. B., Stamm W. E. A primate model for chancroid. J Infect Dis. 1994 Jun;169(6):1284–1290. doi: 10.1093/infdis/169.6.1284. [DOI] [PubMed] [Google Scholar]
  129. Totten P. A., Stamm W. E. Clear broth and plate media for culture of Haemophilus ducreyi. J Clin Microbiol. 1994 Aug;32(8):2019–2023. doi: 10.1128/jcm.32.8.2019-2023.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Trees D. L., Arko R. J., Morse S. A. Mouse subcutaneous chamber model for in vivo growth of Haemophilus ducreyi. Microb Pathog. 1991 Nov;11(5):387–390. doi: 10.1016/0882-4010(91)90025-6. [DOI] [PubMed] [Google Scholar]
  131. Tuffrey M., Alexander F., Ballard R. C., Taylor-Robinson D. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi. J Exp Pathol (Oxford) 1990 Apr;71(2):233–244. [PMC free article] [PubMed] [Google Scholar]
  132. Tyndall M. W., Plourde P. J., Agoki E., Malisa W., Ndinya-Achola J. O., Plummer F. A., Ronald A. R. Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1. Am J Med. 1993 Mar 22;94(3A):85S–88S. [PubMed] [Google Scholar]
  133. Tyndall M., Malisa M., Plummer F. A., Ombetti J., Ndinya-Achola J. O., Ronald A. R. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis. 1993 Feb;167(2):469–471. doi: 10.1093/infdis/167.2.469. [DOI] [PubMed] [Google Scholar]
  134. Van Dyck E., Bogaerts J., Smet H., Tello W. M., Mukantabana V., Piot P. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda. Antimicrob Agents Chemother. 1994 Jul;38(7):1647–1648. doi: 10.1128/aac.38.7.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Vanden Berghe D. A. Selenium and the growth of Haemophilus ducreyi. J Clin Pathol. 1987 Oct;40(10):1174–1177. doi: 10.1136/jcp.40.10.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Wasserheit J. N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992 Mar-Apr;19(2):61–77. [PubMed] [Google Scholar]
  137. Weiser J. N., Gotschlich E. C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun. 1991 Jul;59(7):2252–2258. doi: 10.1128/iai.59.7.2252-2258.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Willson P. J., Albritton W. L., Slaney L., Setlow J. K. Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi. Antimicrob Agents Chemother. 1989 Sep;33(9):1627–1630. doi: 10.1128/aac.33.9.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES